DDS.
2023 Diagnostics & Discovery Summit.
Stay Ahead of the Industry
MAY 16-17
BOSTON MA
Shaping the future of precision medicine.
The inaugural summit will highlight new insights and advances across diagnostics and discovery, with a particular emphasis on multi-omics applications. DDS 2023 promises to be an unparalleled opportunity for leading experts and innovators in precision medicine to learn, connect and exchange ideas.
Expert speakers.
Learn from renowned keynote speakers, participate in engaging panel discussions, and network with esteemed colleagues from across the industry.
Engaging topics.
The event will cover a range of topics including bridging barriers between pharma and biotech research and clinical diagnostics, discovery applications such as target identification, trial design optimization, and population research, as well as clinical applications including lab automation, clinical interpretation, and assay optimization.
Explore the future.
Velsera is uniquely capable of pioneering robust and unifying technology-enabled solutions that allow for a continuous flow of knowledge across biopharma and healthcare. The summit will provide attendees with the opportunity to learn about Velsera's vision and unique approach to the precision medicine and omics insights space.
Our Speakers
14
FEATURED SPEAKERS
01
Michael S. Noble
Michael S. Noble
Chief Data Officer
Break Through Cancer
Michael Noble has over 20 years of experience leading interdisciplinary data analysis and engineering systems in various fields, including cancer genomics, astrophysics, and immunology. He has played a critical role in several significant scientific projects such as the Chandra X-Ray Observatory, TCGA, and GTEx. With degrees in pure mathematics and computer science, Mike has lead- or co-authored publications and datasets that have collectively resulted in over 120K citations.
FOLLOW
Adam C. Resnick, PhD
Director of Data Driven Discovery in Biomedicine (D3b)
Children's Hospital of Philadelphia (CHOP)
Dr. Resnick leads the effort to build scalable patient-focused healthcare and educational discovery ecosystems for children while overseeing bioinformatics, genomics, and software development across multiple center initiatives. He serves as Scientific Chair for multiple consortia-based efforts, including the Children's Brain Tumor Network (CBTN) and Pacific Pediatric Neuro-Oncology Consortium (PNOC), involving over 20 pediatric hospitals globally.
02
Adam C. Resnick, PhD
FOLLOW
03
Meghan M. Dierks, MD, FACS
Meghan M. Dierks, MD, FACS
Chief Data Officer
Komodo Health
Dr. Dierks is an expert in AI and machine learning strategies for precision medicine, with extensive experience in evaluating the clinical and economic risks of new technologies. She has held leadership positions at Beth Israel Deaconess Medical Center, Magellan Health, Lumeris Health Outcomes, and GE Healthcare IT. Dr. Dierks is a board-certified general surgeon a with training fellowships in biomedical informatics and molecular genetics, and has served on numerous federal advisory and review panels.
FOLLOW
Dan Harma, MBA
Chief Commercial Officer
Pillar Biosciences
Mr. Harma has over 30 years of experience leading commercial organizations in the medical device industry, including in-vitro diagnostics, hematology and molecular diagnostics. His leadership is helping to advance the field of precision medicine by driving the accessibility to oncology diagnostics by localizing NGS testing to laboratories across the globe.
04
Dan Harma, MBA
FOLLOW
05
Jonathan Anderson
Jonathan Anderson
National Director of Laboratory Operations
Solaris Health
With over 15 years of experience in clinical laboratory operations and management, Jonathan Anderson has not only built one of most technologically advanced urologic pathology labs in the US but he has also establsihed a clinical pathology lab, providing physicians with access to clinical testing meeting the highest standards and quality of care.
FOLLOW
Rebecca Boyles
Director, Center for Data Modernisation Solutions
Research Triangle Institute
Rebecca Boyles is the Founding Director of the Center for Data Modernization Solutions at RTI International, Co-PI of the NHLBI BioData Catalyst Coordinating Center, and Co-PI on the NIH Helping to End Addiction Long-term (HEAL) Initiative HEAL Data Stewards effort.
06
Rebecca Boyles
FOLLOW
07
Malur Sudhanva O.B.E., MBBS, MD, FRCPath (Virology)
Malur Sudhanva O.B.E., MBBS, MD, FRCPath (Virology)
Consultant Medical Virologist, South London Specialist Virology Centre, Infection Sciences, King’s College NHS Foundation Trust and Honorary Senior Clinical Advisor Public Health and Clinical Oversight (PHCO), UK Health Security Agency
Dr. Sudhanva has been a Consultant Medical Virologist at King’s College Hospital since 2004, and is the former chair of the Panel of Examiners in Virology at the Royal College of Pathologists, and has held several roles with the Royal College of Pathologists, and with multiple other academic organisations.
FOLLOW
Kevin Haas, PhD
Chief Technology Officer at Myriad Genetics
Dr Haas an innovative leader of diverse teams across Tech and R&D currently responsible for building Myriad's precision medicine platform to improve the patient/provider experience through digital engagement, harnessing genetic data, and powering breakthrough products to serve millions of customers. He has expertise in AI and machine learning applied to biophysical systems and genetics
08
FOLLOW
Kevin Haas, PhD
09
Ed Esplin, MD, PhD, FACMG, FACP
Ed Esplin, MD, PhD, FACMG, FACP
Clinical Geneticist,
Invitae
Dr. Esplin is board certified in clinical genetics and internal medicine and heads clinical studies and medical information at Invitae.
FOLLOW
Sudheer Doss, PhD
Chief Business Officer & Head of Patient Health Data at the Pancreatic Cancer Action Network (PanCAN)
Dr. Doss combines scientific expertise in genomics and bioinformatics with 15+ years experience in strategic and operational initiatives in precision medicine and is responsible for creating the PanCAN's data and technology vision and strategy.
10
Sudheer Doss, PhD
FOLLOW
11
Ana Maria Florescu, PhD
Ana Maria Florescu, PhD
Associate Director, Precision Oncology and Virology
Molecular Partners
Dr. Florescu is leading the precision medicine group at Molecular Partners that covers hematological malignancies, solid tumors and virology ranging from discovery to early clinical development. With experience ranging from target identification to clincial biomarker data analysis, her main focus is to advance the understanding of disease biology and help deliver more efficient drugs using multimodal data.
FOLLOW
Charles Cartwright, PhD
Vice President of Strategic Development
Serosep Ltd.
Dr. Cartwright has an extensive background in clinical microbiology and molecular diagnostics with a wealth of experience in formulating roadmaps for laboratory growth and developing strategic partnerships with healthcare systems.
12
Charles Cartwright, PhD
FOLLOW
13
%20Boerkoel.jpeg)
Neal Boerkoel, MD, PhD
Neal Boerkoel, MD, PhD
President
Alamya Health
A founder of Alamya Health and former Executive Clinical Director of the Sanford Genetics Laboratories, laboratory director at the NIH Undiagnosed Diseases Program, and co-founder of the Rare Disease Foundation, Dr. Boerkoel brings 40+ years of research and clinical expertise in genetic medicine, namely precision medicine and precision prevention.
FOLLOW
Jason Gillman, MS
Sr. Director of Operations, Precision Health
Intermountain Healthcare
Jason Gillman has extensive experience in genomics program administration, operations management, and healthcare with multiple awards, including recognition from Fast Company's World's Most Innovative Companies list and the Governor's Medal for Science and Technology.
FOLLOW
14
Jason Gillman, MS
Agenda
AT A GLANCE
TUESDAY MAY 16
7:00
Breakfast & arrival
9:00 - 5:00
Engaging keynote presentations, breakout session, and Velsera product sneak peeks
5:30
Happy hour
7:00
Dinner
WEDNESDAY MAY 17
7:00
Breakfast
9:00 - 1:00
Engaging keynote presentations, breakout session, and Velsera product sneak peeks
1:30
Closing remarks & lunch
The Venue
776 Boylston St,
Boston, MA 02199
An intimately luxurious hotel, Mandarin Oriental, Boston combines classic New England elegance with refined Oriental touches to create one of the most distinctive hospitality experiences in the region.
Our Participants
ARE LEADING IN THE INDUSTRY